Fendy Yanhui Feng, vice president of Eisai Co., Ltd. and president of Eisai China Holdings Ltd. and Eisai China Inc., shares the significant improvements she has made to Eisai’s China Region operations over the past five years across; the affiliate’s exciting launch of LENVIMA® in 2018 and more upcoming launches to look forward to; the strategic significance of China as Eisai’s third-largest market; and the importance of reacting quickly to the changing market dynamics in China.
Many other MNCs have been recruiting more medical reps to increase their coverage, particularly in lower-tier areas. Instead of doing this, we focused on generating and maximizing synergies between different teams
